Compounds > epirubicin
Page last updated: 2024-08-23

epirubicin and Epithelial Ovarian Cancer

epirubicin has been researched along with Epithelial Ovarian Cancer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
An, Q; Geng, HX; Li, XT; Liu, JT; Lu, XH; Tang, L; Wang, YJ; Wang, YY1
Chen, X; Dai, H; Qian, Z; Wang, Y; Xu, X; Zhao, Y1
Borani, N; Karalök, MA; Keskin, HL; Köse, MF; Özgül, N; Tulunay, HG; Turan, AT; Üreyen, I1

Other Studies

3 other study(ies) available for epirubicin and Epithelial Ovarian Cancer

ArticleYear
Efficacy of epi-1 modified epirubicin and curcumin encapsulated liposomes targeting-EpCAM in the inhibition of epithelial ovarian cancer cells.
    Journal of liposome research, 2023, Volume: 33, Issue:2

    Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Curcumin; Epirubicin; Epithelial Cell Adhesion Molecule; Female; Humans; Liposomes; Ovarian Neoplasms

2023
In vitro chemosensitivity assay of ascites in epithelial ovarian cancer.
    European journal of gynaecological oncology, 2013, Volume: 34, Issue:6

    Topics: Antineoplastic Agents; Ascites; Carboplatin; Carcinoma, Ovarian Epithelial; Coloring Agents; Deoxycytidine; Disease Progression; Drug Screening Assays, Antitumor; Epirubicin; Etoposide; Female; Fluorouracil; Gemcitabine; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Survival Rate; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2013
Addition of epirubicin to conventional chemotherapy in patients with advanced ovarian cancer: sequential therapy -a retrospective evaluation. .
    Turkish journal of medical sciences, 2014, Volume: 44, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Cisplatin; Cytoreduction Surgical Procedures; Disease-Free Survival; Epirubicin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Young Adult

2014